Related Experiment Videos
Differentiation of retroperitoneal tumor using positron emission computed tomography
Journal of Computer Assisted Tomography
|December 1, 1979
Summary
Positron emission computed tomography (ECT) using 11C-DL-tryptophan and 11C-aminocyclobutanecarboxylic acid (11C-ACBC) shows promise for differentiating retroperitoneal masses. Dual radiopharmaceuticals helped distinguish a pancreatic tumor from normal pancreatic tissue.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiochemistry
Background:
- Retroperitoneal masses pose diagnostic challenges, often requiring advanced imaging.
- Transmission computed tomography (CT) and arteriography can be inconclusive for differentiating pancreatic lesions.
Observation:
- A patient presented with a retroperitoneal mass initially indistinguishable from the pancreas via CT.
- Arteriographic findings suggested a pancreatic origin for the mass.
Findings:
- Positron emission computed tomography (ECT) with 11C-DL-tryptophan indicated a normal pancreas.
- The novel tumor-avid agent 11C-aminocyclobutanecarboxylic acid (11C-ACBC) showed significant uptake in the retroperitoneal mass, localizing it to the pancreatic body and tail.
Implications:
- Dual-tracer ECT offers a potential method for differentiating metabolically active neoplasms from normal tissues.
- This approach warrants further investigation for improved diagnosis of retroperitoneal masses.